X Enter your email address here:
Loading
The International Network
of Orthodox Mental Health Professionals
Like/Follow us today!
The browser you're using is not supported. Please try again using a supported browser such as Firefox or Chrome

Click here to open the FAQ page

Add this Webinar to Your Calendar! 11/03/2020 08:00 AM 11/03/2020 10:00 AM How Psychedelics Can Revolutionize Psychiatry
Drugs that induce a distinctive subjective altered state of consciousness, collectively referred to as “psychedelics,” stand to revolutionize the treatment of mental disorders. At present only one such drug, ketamine, is FDA approved for human use and, therefore, can be prescribed (off-label) to treat mental illness. However, many more psychedelics are under development including MDMA and psilocybin, which have been given “fast track” designation by the FDA.  In this presentation, Dr. Feifel will provide an overview of the psychedelics, focusing on ketamine, but discussing others such NMDA and psilocybin, and their impact on the treatment of mental illness.
https://nefesh.org/workshops/psychedelics/view
NEFESH ALL POINTS NORTH LODGE Professional Development

How Psychedelics Can Revolutionize Psychiatry

Previously Recorded

Presenter: David Feifel MD PHD

Please enter your name and email address below to view this course:


Tell us how you heard about us:


Course Length: 1 Hour & 30 Minutes

Learning Objectives:
  1. will be able to describe a psychedelic agent
  2. will be able to describe their role in psychiatric treatment
  3. will be able to potentially utilize them in their clinical practice
Refund Policy: Full Refund until 48 hours before scheduled date.
48 hours before: full refund less $5.00 processing fee. After event no refund will be given.
*exclusions apply for reasonable need and cause.

This webinar offers 1.5 ASWB/NYS ED Self Study Credits

Drugs that induce a distinctive subjective altered state of consciousness, collectively referred to as “psychedelics,” stand to revolutionize the treatment of mental disorders. At present only one such drug, ketamine, is FDA approved for human use and, therefore, can be prescribed (off-label) to treat mental illness. However, many more psychedelics are under development including MDMA and psilocybin, which have been given “fast track” designation by the FDA.  In this presentation, Dr. Feifel will provide an overview of the psychedelics, focusing on ketamine, but discussing others such NMDA and psilocybin, and their impact on the treatment of mental illness.
Learning Objectives:
  1. will be able to describe a psychedelic agent
  2. will be able to describe their role in psychiatric treatment
  3. will be able to potentially utilize them in their clinical practice
Refund Policy: Full Refund until 48 hours before scheduled date.
48 hours before: full refund less $5.00 processing fee. After event no refund will be given.
*exclusions apply for reasonable need and cause.

This presentation is open to:
  • Social Workers
  • Professional Counselors
  • Therapists
  • Psychologists
  • Licensed Mental Health Practitioners
  • Other professionals interacting with populations engaged in mental health based services
And is beneficial for:
  • New practitioners who wish to gain enhanced insight surrounding the topic
  • Experienced practitioners who seek to increase and expand fundamental knowledge surrounding the subject matter
  • Advanced practitioners seeking to review concepts and reinforce practice skills and/or access additional consultation
  • Managers seeking to broaden micro and/or macro perspectives

Participants will receive their certificate electronically upon completion of the webinar and course evaluation form.


  • NEFESH International is recognized by the New York State Education Department’s State Board for Social Work as an Approved Provider of Continuing Education for Licensed Social Workers (#SW-0048), and by the NYSED’s State Board for Mental Health Practitioners as an Approved Provider of Continuing Education for Licensed Marriage and Family Therapists (#MFT-0046) and Licensed Mental Health Counselors (#MHC-0082).